Xenetic Biosciences
XBIO
8 hedge funds and large institutions have $187K invested in Xenetic Biosciences in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.47% less ownership
Funds ownership: 0.87% → 0.4% (-0.47%)
11% less funds holding
Funds holding: 9 → 8 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
74% less capital invested
Capital invested by funds: $724K → $187K (-$537K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$50.3K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$35 |
| 3 |
DWM
Darwin Wealth Management
Tampa,
Florida
|
+$12 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$238K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$79K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$36K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $122K | +$50.3K | +4,332 | +36% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $45K | -$238K | -20,498 | -77% |
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $20K | – | – | – |
|
|
RE
4
RBC Europe
London,
United Kingdom
| $78 | – | – | – |
|
|
OAM
5
Oxford Asset Management
Oxford,
United Kingdom
| – | -$79K | -5,475 | Closed |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$36K | -2,544 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$14K | -976 | Closed |
|
|
DWM
8
Darwin Wealth Management
Tampa,
Florida
| – | +$12 | +1 | New |
|
|
9
Wells Fargo
San Francisco,
California
| – | +$35 | +3 | New |
|
XBIO Hedge Fund Activity: Q1 2020 in Review
8 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q1 2020, worth a combined $187K — down 74% from $724K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of XBIO and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $50.3K. The largest seller was Sabby Management, cutting an estimated $238K.
- 8 institutional investors held Xenetic Biosciences (XBIO) as of Q1 2020, down from 9 in Q4 2019.
- Funds reported $187K of Xenetic Biosciences stock for Q1 2020, down 74% quarter-over-quarter.
- 2 funds opened new Xenetic Biosciences positions in Q1 2020 and 3 closed out, a net change of -1 holder.
- The largest Xenetic Biosciences buyer in Q1 2020 was Renaissance Technologies, an estimated $50.3K added.
- The largest Xenetic Biosciences seller in Q1 2020 was Sabby Management, an estimated $238K sold.
Based on aggregated 13F filings for Q1 2020.